Vietnam Medical and Pharmaceutical Investment JSC (HOSE:JVC)
5,650.00
-60.00 (-1.05%)
At close: Feb 27, 2026
HOSE:JVC Balance Sheet
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Mar '17 Mar 31, 2017 | Mar '16 Mar 31, 2016 |
Cash & Equivalents | 29,238 | 19,582 | 152,937 | 30,306 | 8,688 |
Short-Term Investments | 13,436 | 607.53 | 579.69 | 7,194 | 7,869 |
Cash & Short-Term Investments | 42,674 | 20,189 | 153,516 | 37,500 | 16,557 |
Cash Growth | 111.37% | -86.85% | 309.38% | 126.49% | -97.88% |
Accounts Receivable | 276,002 | 119,243 | 142,334 | 131,704 | 136,993 |
Other Receivables | 137,498 | -236,824 | -364,983 | -494,997 | -466,845 |
Receivables | 418,076 | -112,880 | -222,650 | -362,793 | -327,623 |
Inventory | 123,431 | 152,827 | 53,014 | 77,196 | 161,139 |
Prepaid Expenses | 2,284 | 1,667 | 4,082 | 1,287 | 101.32 |
Other Current Assets | 152,868 | 500,492 | 540,463 | 517,551 | 491,299 |
Total Current Assets | 739,333 | 562,295 | 528,425 | 270,741 | 341,474 |
Property, Plant & Equipment | 122,428 | 105,186 | 141,550 | 439,228 | 474,250 |
Long-Term Investments | 192,800 | 140,000 | - | - | 1,502 |
Other Intangible Assets | 1,021 | 1,319 | 1,554 | 53.57 | 74.3 |
Long-Term Accounts Receivable | - | - | - | - | 6,096 |
Long-Term Deferred Tax Assets | 2,223 | 1,261 | 363.64 | - | - |
Other Long-Term Assets | 16,231 | 18,042 | 14,784 | 22,573 | 18,093 |
Total Assets | 1,074,036 | 828,103 | 686,677 | 732,595 | 841,489 |
Accounts Payable | 83,633 | 87,796 | 48,302 | 115,027 | 69,351 |
Accrued Expenses | 20,426 | 19,985 | 25,763 | 22,527 | 19,344 |
Short-Term Debt | 273,143 | 140,829 | 92,726 | - | - |
Current Portion of Long-Term Debt | - | - | - | 1,605 | 2,181 |
Current Portion of Leases | - | - | - | 12,012 | 12,012 |
Current Income Taxes Payable | 13,785 | 19,136 | 3,273 | 312.77 | 31,245 |
Other Current Liabilities | 26,764 | 20,540 | 15,032 | 11,449 | 27,830 |
Total Current Liabilities | 417,751 | 288,286 | 185,096 | 162,933 | 161,963 |
Long-Term Debt | 29,939 | - | - | 2,710 | 6,010 |
Long-Term Leases | - | - | - | 19,394 | 31,407 |
Long-Term Deferred Tax Liabilities | 62.74 | 135.01 | 1,337 | 378.54 | 313.7 |
Other Long-Term Liabilities | - | - | 898.6 | 22,454 | 85,376 |
Total Liabilities | 447,753 | 288,421 | 187,331 | 207,869 | 285,069 |
Common Stock | 1,125,002 | 1,125,002 | 1,125,002 | 1,125,002 | 1,125,002 |
Additional Paid-In Capital | 402,288 | 402,288 | 402,288 | 402,288 | 402,288 |
Retained Earnings | -938,262 | -987,859 | -1,028,141 | -1,002,564 | -970,870 |
Total Common Equity | 589,028 | 539,431 | 499,149 | 524,726 | 556,420 |
Minority Interest | 37,255 | 250.16 | 196.29 | - | - |
Shareholders' Equity | 626,283 | 539,682 | 499,346 | 524,726 | 556,420 |
Total Liabilities & Equity | 1,074,036 | 828,103 | 686,677 | 732,595 | 841,489 |
Total Debt | 303,082 | 140,829 | 92,726 | 35,721 | 51,611 |
Net Cash (Debt) | -260,409 | -120,639 | 60,790 | 1,778 | -35,054 |
Net Cash Growth | - | - | 3318.23% | - | - |
Net Cash Per Share | -2315.48 | -1072.35 | 540.36 | 15.81 | -311.59 |
Filing Date Shares Outstanding | 112.5 | 112.5 | 112.5 | 112.5 | 112.5 |
Total Common Shares Outstanding | 112.5 | 112.5 | 112.5 | 112.5 | 112.5 |
Working Capital | 321,582 | 274,009 | 343,330 | 107,808 | 179,511 |
Book Value Per Share | 5235.80 | 4794.94 | 4436.88 | 4664.22 | 4945.95 |
Tangible Book Value | 588,007 | 538,112 | 497,595 | 524,672 | 556,346 |
Tangible Book Value Per Share | 5226.72 | 4783.21 | 4423.06 | 4663.75 | 4945.29 |
Buildings | 4,695 | 4,695 | 4,695 | 974.24 | 1,025 |
Machinery | 604,641 | 568,295 | 549,553 | 767,661 | 833,804 |
Construction In Progress | 2,242 | 5,239 | 38,790 | 2,177 | 2,568 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.